Suchergebnisse - "André, Nicolas"

PubPharm (428)

81

PRMT1 Regulates EGFR and Wnt Signaling Pathways and Is a Promising Target for Combinatorial Treatment of Breast Cancer

in: Cancers | 2022

von Samyuktha Suresh | Solène Huard | Amélie Brisson | +15

82

Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma

in: Journal for ImmunoTherapy of Cancer | 2022

von Birgit Geoerger | Aurélien Marabelle | Gaelle Pierron | +26

83

Pharmacokinetics of oral vinorelbine in French children with recurrent or progressive primary low‐grade glioma

enthalten in: British Journal of Clinical Pharmacology | 2022

von Hamimed, M. | Gattacceca, F. | André, N. | +12

84

Trametinib for a BRAF G469A missense mutation in a neuroblastoma unveiled by liquid biopsy

enthalten in: Pediatric Blood & Cancer | 2022

von Toutain, G. | Min, V. | Rome, A. | +1

85

Six‐month BNT162b2 vaccine efficacy in adolescents and young adults with cancer

enthalten in: Pediatric Blood & Cancer | 2022

von Donze, C. | Ninove, L. | Lamballerie, X. | +2

86

First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies : arms E and F of the AcSé-ESMART trial

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Morscher, R. | Brard, C. | Berlanga, P. | +14

87

Phase I or II Study of Ribociclib in Combination With Topotecan-Temozolomide or Everolimus in Children With Advanced Malignancies : Arms A and B of the AcSé-ESMART Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Bautista, F. | Paoletti, X. | Rubino, J. | +14

CommentIn: J Clin Oncol. 2021 Nov 10;39(32):3527-3530. - PMID 34559549

88

Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes : a Rare Brain Tumor Registry study

enthalten in: The Lancet. Child & adolescent health | 2021

von Khan, S. | Solano-Paez, P. | Suwal, T. | +119

89

Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Malissen, N. | Ninove, L. | de Lamballerie, X. | +2

90

Favorable Outcome of COVID-19 Infection in a Pediatric Cancer Patient Receiving an Anti-PD-L1/Anti-CTLA-4 Combination

enthalten in: Journal of pediatric hematology/oncology | 2021

von Revon-Riviere, G. | Soler, C. | Andrianarivony, T. | +2